For patients with incidental findings of venous thromboembolism during workup of a treatable malignancy, how do you approach discontinuation after the treatment is complete?  

Would you consider low dose indefinite anticoagulation in any scenario? Any difference in approach between hematological malignancy and solid tumors?

Answer from: Medical Oncologist at Academic Institution